Sakaguchi, S., Yamaguchi, T., Nomura, T. & Ono, M.
Regulatory T cells and immune tolerance. Cell
133, 775–787 (2008).
Duarte, J. H., Zelenay, S., Bergman, M. L., Martins, A. C. & Demengeot, J.
Natural Treg cells spontaneously differentiate into pathogenic helper cells in lymphopenic conditions. Eur. J. Immunol.
39, 948–955 (2009).
et al. Plasticity of Foxp3+ T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells. Immunity.
36, 262–275 (2012).
Vignali, D. A. A., Collison, L. W. & Workman, C. J.
How regulatory T cells work. Nature Rev. Immunol.
8, 523–532 (2008).
Benoist, C. & Mathis, D.
Treg cells, life history, and diversity. Cold Spring Harb. Perspect. Biol.
4, a007021 (2012).
Rudensky, A. Y.
Regulatory T cells and Foxp3. Immunol. Rev.
241, 260–268 (2011).
et al. A multiply redundant genetic switch 'locks in' the transcriptional signature of regulatory T cells. Nature Immunol.
13, 972–980 (2012).
et al. T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development. Immunity
37, 785–799 (2012).
Regulatory T cells: history and perspective. Methods Mol. Biol.
707, 3–17 (2011).
Workman, C. J., Szymczak-Workman, A. L., Collison, L. W., Pillai, M. R. & Vignali, D. A.
The development and function of regulatory T cells. Cell. Mol. Life Sci.
66, 2603–2622 (2009).
Collison, L. W., Pillai, M. R., Chaturvedi, V. & Vignali, D. A.
Regulatory T cell suppression is potentiated by target T cells in a cell contact, IL-35- and IL-10-dependent manner. J. Immunol.
182, 6121–6128 (2009).
Abbas, A. K.
et al. Regulatory T cells: recommendations to simplify the nomenclature. Nature Immunol.
14, 307–308 (2013).
Rubtsov, Y. P.
et al. Stability of the regulatory T cell lineage in vivo. Science
329, 1667–1671 (2010).
et al. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nature Immunol.
10, 1000–1007 (2009).
Hori, S., Nomura, T. & Sakaguchi, S.
Control of regulatory T cell development by the transcription factor Foxp3. Science
299, 1057–1061 (2003).
Fontenot, J. D.
et al. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity
22, 329–341 (2005).
Williams, L. M. & Rudensky, A. Y.
Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nature Immunol.
8, 277–284 (2007).
Samstein, R. M.
et al. Foxp3 exploits a pre-existent enhancer landscape for regulatory T cell lineage specification. Cell
151, 153–166 (2012).
Stability of regulatory T-cell lineage. Adv. Immunol.
112, 1–24 (2011).
Sakaguchi, S., Miyara, M., Costantino, C. M. & Hafler, D. A.
FOXP3+ regulatory T cells in the human immune system. Nature Rev. Immunol.
10, 490–500 (2010).
Tian, L., Humblet-Baron, S. & Liston, A.
Immune tolerance: are regulatory T cell subsets needed to explain suppression of autoimmunity?
34, 569–575 (2012).
et al. Phosphorylation of FOXP3 controls regulatory T cell function and is inhibited by TNF-α in rheumatoid arthritis. Nature Med.
19, 322–328 (2013).
Zhou, X., Bailey-Bucktrout, S., Jeker, L. T. & Bluestone, J. A.
Plasticity of CD4+ FoxP3+ T cells. Curr. Opin. Immunol.
21, 281–285 (2009).
et al. Distinct inflammatory signals have physiologically divergent effects on epigenetic regulation of Foxp3 expression and Treg function. Am. J. Transplant.
11, 203–214 (2011).
et al. Inflammation-driven reprogramming of CD4+ Foxp3+ regulatory T cells into pathogenic Th1/Th17 T effectors is abrogated by mTOR inhibition in vivo. PLoS ONE
7, e35572 (2012).
d'Hennezel, E., Yurchenko, E., Sgouroudis, E., Hay, V. & Piccirillo, C. A.
Single-cell analysis of the human T regulatory population uncovers functional heterogeneity and instability within FOXP3+ cells. J. Immunol.
186, 6788–6797 (2011).
Pasare, C. & Medzhitov, R.
Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science
299, 1033–1036 (2003).
Koch, M. A.
et al. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nature Immunol.
10, 595–602 (2009).
et al. CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner. Science
326, 986–991 (2009).
et al. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control TH2 responses. Nature
458, 351–356 (2009).
Polansky, J. K.
et al. DNA methylation controls Foxp3 gene expression. Eur. J. Immunol.
38, 1654–1663 (2008).
et al. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature
463, 808–812 (2010).
Josefowicz, S. Z.
et al. Extrathymically generated regulatory T cells control mucosal TH2 inflammation. Nature
482, 395–399 (2012).
Josefowicz, S. Z., Lu, L.-F. & Rudensky, A. Y.
Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol.
30, 531–564 (2012).
et al. Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection. Immunity
31, 772–786 (2009).
et al. Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol.
5, e38 (2007).
et al. Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity
30, 155–167 (2009).
et al. Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol.
10, 1969–1980 (1998).
Thornton, A. M. & Shevach, E. M.
CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med.
188, 287–296 (1998).
Daniel, C., Wennhold, K., Kim, H. J. & von Boehmer, H.
Enhancement of antigen-specific Treg vaccination in vivo. Proc. Natl Acad. Sci. USA
107, 16246–16251 (2010).
Cobbold, S. P., Adams, E., Marshall, S. E., Davies, J. D. & Waldmann, H.
Mechanisms of peripheral tolerance and suppression induced by monoclonal antibodies to CD4 and CD8. Immunol. Rev.
149, 5–33 (1996).
Chang, J. T.
et al. Asymmetric T lymphocyte division in the initiation of adaptive immune responses. Science
315, 1687–1691 (2007).
et al. Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. Immunity
30, 899–911 (2009).
Kendal, A. R.
et al. Sustained suppression by Foxp3+ regulatory T cells is vital for infectious transplantation tolerance. J. Exp. Med.
208, 2043–2053 (2011).
Beier, U. H.
et al. Histone deacetylases 6 and 9 and sirtuin-1 control Foxp3+ regulatory T cell function through shared and isoform-specific mechanisms. Sci. Signal.
5, ra45 (2012).
Zhang, H., Xiao, Y., Zhu, Z., Li, B. & Greene, M. I.
Immune regulation by histone deacetylases: a focus on the alteration of FOXP3 activity. Immunol. Cell Biol.
90, 95–100 (2012).
Wing, J. B. & Sakaguchi, S.
Multiple Treg suppressive modules and their adaptability. Front. Immunol.
3, 178 (2012).
Wang, H. Y. & Wang, R. F.
Regulatory T cells and cancer. Curr. Opin. Immunol.
19, 217–223 (2007).